Chokshi DA, Kesselheim AS - BMJ
The authors challenge three common arguments used to explain inadequate vaccine access in low-income countries—the primacy of infrastructure, insufficient funding, and the need for prior approval in wealthy nations—arguing that each can be overcome with targeted policy interventions. They contend that vaccination programs can themselves strengthen health infrastructure and that mechanisms like advance market commitments and tiered pricing can address funding and access gaps.
VIEW SOURCE
Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics
Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine
Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open